Alembic Pharma surges on USFDA completing inspection at its Bioequivalence facility

alembic pharmaceuticals gets usfda approval for solifenacin succinate tablets

Alembic Pharmaceuticals is currently trading at Rs. 520.00, up by 9.65 points or 1.89% from its previous closing of Rs. 510.35 on the BSE. The scrip opened at Rs. 520.00 and has touched a high and low of Rs. 525.80 and Rs. 517.15 respectively. The BSE group ‘A’ stock of face value Rs. 2 has … Read more

BREAKING NEWS:
Bajaj’s electric bike: No mileage worries ahead! Hyundai i20 Sales Hit 1.5 Million, Launched 18 Years Ago Affordable Fun: Best 5G Smartphones Under ₹15,000!